Shenhong Wu
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 29
- Cancer Treatment and Pharmacology 14
- Cancer Immunotherapy and Biomarkers 12
- Cancer Diagnosis and Treatment 11
- Dermatology top 0.5%
- Internal Medicine top 2%
-
- Renal cell carcinoma treatment 19
- Prostate Cancer Treatment and Research 10
- Hepatology top 2%
-
- PI3K/AKT/mTOR signaling in cancer 9
-
- Chronic Lymphocytic Leukemia Research 8
- Co-authors
- Xiaolei ZhuMario E. LacoutureDavid ChuSanjaykumar HapaniVishal RanpuraWilliam L. DahutRoger KeresztesChirag R. Parikh
- Cited by
- OncologyDermatologyInternal Medicine
- Partner nations
- United StatesCanadaChina
In The Last Decade
Shenhong Wu
94 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 2.9k
- Dermatology 716
- Internal Medicine 289
- Pulmonary and Respiratory Medicine 1.7k
- Hepatology 351
Countries citing papers authored by Shenhong Wu
This map shows the geographic impact of Shenhong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenhong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenhong Wu more than expected).
Fields of papers citing papers by Shenhong Wu
This network shows the impact of papers produced by Shenhong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenhong Wu. The network helps show where Shenhong Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shenhong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 7 | |
| 4 | 2019 | 11 | |
| 5 | 2019 | 16 | |
| 6 | 2017 | 49 | |
| 7 | 2015 | 28 | |
| 8 | 2015 | 25 | |
| 9 | 2014 | 6 | |
| 10 | 2013 | 30 | |
| 11 | 2012 | 42 | |
| 12 | 2011 | 21 | |
| 13 | 2010 | 4 | |
| 14 | 2009 | 53 | |
| 15 | 2008 | 0 | |
| 16 | 2008 | 246 | |
| 17 | 2008 | 162 | |
| 18 | 2007 | 34 | |
| 19 | 2007 | 44 | |
| 20 | 2007 | 14 |
About Shenhong Wu
Shenhong Wu is a scholar working on Oncology, Dermatology and Pulmonary and Respiratory Medicine, having authored 96 papers that have together received 5.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (29 papers), Renal cell carcinoma treatment (19 papers), Cancer Treatment and Pharmacology (14 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Oncology (2.9k citations), Dermatology (716 citations) and Internal Medicine (289 citations). Shenhong Wu has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Xiaolei Zhu, Mario E. Lacouture, David Chu, Sanjaykumar Hapani, Vishal Ranpura, William L. Dahut, Roger Keresztes, Chirag R. Parikh, Kathleen Stergiopoulos and Viswanath Reddy Belum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.